These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 34646060)

  • 1. Compelling Evidence Suggesting the Codon Usage of SARS-CoV-2 Adapts to Human After the Split From RaTG13.
    Zhang Y; Jin X; Wang H; Miao Y; Yang X; Jiang W; Yin B
    Evol Bioinform Online; 2021; 17():11769343211052013. PubMed ID: 34646060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SARS-CoV-2 continuously optimizes its codon usage to adapt to human lung environment.
    Wang Y; Li Z; Wang X; Jiang W; Jiang W
    J Appl Genet; 2023 Dec; 64(4):831-837. PubMed ID: 37740828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GC usage of SARS-CoV-2 genes might adapt to the environment of human lung expressed genes.
    Li Y; Yang X; Wang N; Wang H; Yin B; Yang X; Jiang W
    Mol Genet Genomics; 2020 Nov; 295(6):1537-1546. PubMed ID: 32888056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative Genomic Analyses Reveal a Specific Mutation Pattern Between Human Coronavirus SARS-CoV-2 and Bat-CoV RaTG13.
    Lv L; Li G; Chen J; Liang X; Li Y
    Front Microbiol; 2020; 11():584717. PubMed ID: 33424784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis B virus (HBV) codon adapts well to the gene expression profile of liver cancer: an evolutionary explanation for HBV's oncogenic role.
    Yu C; Li J; Li Q; Chang S; Cao Y; Jiang H; Xie L; Fan G; Wang S
    J Microbiol; 2022 Nov; 60(11):1106-1112. PubMed ID: 36251120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multivariate analyses of codon usage of SARS-CoV-2 and other betacoronaviruses.
    Gu H; Chu DKW; Peiris M; Poon LLM
    Virus Evol; 2020 Jan; 6(1):veaa032. PubMed ID: 32431949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative analysis of human coronaviruses focusing on nucleotide variability and synonymous codon usage patterns.
    Das JK; Roy S
    Genomics; 2021 Jul; 113(4):2177-2188. PubMed ID: 34019999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparative genomics-based study of positive strand RNA viruses emphasizing on SARS-CoV-2 utilizing dinucleotide signature, codon usage and codon context analyses.
    Saha J; Bhattacharjee S; Pal Sarkar M; Saha BK; Basak HK; Adhikary S; Roy V; Mandal P; Chatterjee A; Pal A
    Gene Rep; 2021 Jun; 23():101055. PubMed ID: 33615042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of 3.5 million SARS-CoV-2 sequences reveals unique mutational trends with consistent nucleotide and codon frequencies.
    Fumagalli SE; Padhiar NH; Meyer D; Katneni U; Bar H; DiCuccio M; Komar AA; Kimchi-Sarfaty C
    Virol J; 2023 Feb; 20(1):31. PubMed ID: 36812119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deciphering the co-adaptation of codon usage between respiratory coronaviruses and their human host uncovers candidate therapeutics for COVID-19.
    Nambou K; Anakpa M
    Infect Genet Evol; 2020 Nov; 85():104471. PubMed ID: 32707288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of codon usage pattern in SARS-CoV-2.
    Hou W
    Virol J; 2020 Sep; 17(1):138. PubMed ID: 32928234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Codon usage divergence in Delta variants (B.1.617.2) of SARS-CoV-2.
    Li G; Zhang L; Xue P
    Infect Genet Evol; 2022 Jan; 97():105175. PubMed ID: 34871776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relative synonymous codon usage of ORF1ab in SARS-CoV-2 and SARS-CoV.
    Li G; Zhang L; Du N
    Genes Genomics; 2021 Nov; 43(11):1351-1359. PubMed ID: 34228320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative analysis of protein synthesis rate in COVID-19 with other human coronaviruses.
    Dasari CM; Bhukya R
    Infect Genet Evol; 2020 Nov; 85():104432. PubMed ID: 32592845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The
    Li P; Guo R; Liu Y; Zhang Y; Hu J; Ou X; Mi D; Chen T; Mu Z; Han Y; Chen Z; Cui Z; Zhang L; Wang X; Wu Z; Wang J; Jin Q; Qian Z
    Sci Bull (Beijing); 2021 Jun; 66(12):1215-1227. PubMed ID: 33495713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pseudotyped Bat Coronavirus RaTG13 is efficiently neutralised by convalescent sera from SARS-CoV-2 infected patients.
    Cantoni D; Mayora-Neto M; Thakur N; Elrefaey AME; Newman J; Vishwanath S; Nadesalingam A; Chan A; Smith P; Castillo-Olivares J; Baxendale H; Charleston B; Heeney J; Bailey D; Temperton N
    Commun Biol; 2022 May; 5(1):409. PubMed ID: 35505237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The PRRA insert at the S1/S2 site modulates cellular tropism of SARS-CoV-2 and ACE2 usage by the closely related Bat RaTG13.
    Liu S; Selvaraj P; Lien CZ; Nunez IA; Wu WW; Chou CK; Wang TT
    J Virol; 2021 May; 95(11):. PubMed ID: 33685917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SARS-CoV-2 has the advantage of competing the iMet-tRNAs with human hosts to allow efficient translation.
    Wang Y; Gai Y; Li Y; Li C; Li Z; Wang X
    Mol Genet Genomics; 2021 Jan; 296(1):113-118. PubMed ID: 33040198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insertion-and-Deletion Mutations between the Genomes of SARS-CoV, SARS-CoV-2, and Bat Coronavirus RaTG13.
    Akaishi T
    Microbiol Spectr; 2022 Jun; 10(3):e0071622. PubMed ID: 35658573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of codon usage of severe acute respiratory syndrome corona virus 2 (SARS-CoV-2) and its adaptability in dog.
    Dutta R; Buragohain L; Borah P
    Virus Res; 2020 Oct; 288():198113. PubMed ID: 32771430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.